PORCEPTAL 4 MICROGRAMS/ML SOLUTION FOR INJECTION FOR PIGS
Land: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
Vara einkenni
(SPC)
04-11-2016
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
BUSERELIN ACETATE
Fáanlegur frá:
Intervet Ireland Limited
ATC númer:
QH01CA90
INN (Alþjóðlegt nafn):
BUSERELIN ACETATE
Skammtar:
4 Microgram/ML
Lyfjaform:
Solution for Injection
Gerð lyfseðils:
POM
Meðferðarhópur:
Porcine
Lækningarsvæði:
Buserelin
Ábendingar:
Hormone
Leyfisstaða:
Authorised
Leyfisdagur:
2013-12-20
Vara einkenni
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Porceptal 4 micrograms/ml solution for injection for pigs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection
A clear, colourless solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs (gilts and sows)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Induction of ovulation after oestrus synchronisation by weaning (sows) or by administration of a progestin (gilts) to be
used as part of a single fixed time artificial insemination program.
4.3 CONTRAINDICATIONS
None
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Buserelin is given after oestrus synchronisation. In gilts, buserelin is given after progestin treatment. Provided that the
progestin treatment is ended simultaneously in a group of gilts, it causes a synchronisation of oestrus in the treated
animals. In sows, oestrus synchronisation is achieved naturally by weaning.
Insemination can be done at 30-33 hours after buserelin injection. When using this product, the animals should be
checked for signs of oestrus at the time of artificial insemination. Therefore the presence of the boar is recommended.
It may happen that negative energy balance during lactation is associated with mobilisation of body reserves with a
large drop in backfat thickness (more than approximately 30 %). In such animals, oestrus and ovulation may be delayed
and these animals should be managed and bred on a case by case basis.
Per ml:
ACTIVE SUBSTANCE:
Buserelin acetate
4.2 µg
(corresponding to 4 µg buserelin)
EXCIPIENTS:
Benzyl alcohol E1519
20.0 mg
For a full list of excipients, see section 6.1.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Da
Lestu allt skjalið
